SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : IDPH--Positive preliminary results for pivotal trial of ID
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Roader who wrote (827)5/8/1997 2:24:00 PM
From: I. Luttichuys   of 1762
 
Hello Roader, I think these numbers are very encouraging and speak well to the management at IDEC. It is interesting to me that we have not seen a stronger response in the stock this morning but, we have recently come off a very decent run-up and the buying in IDEC often seems to begin in the late afternoon so we will see. IMHO we are still in a very oversold state given the fundamentals and impending FDA action which has a good chance of being favourable! The pipeline is outstanding as well which we all know.
Interesting to note that C2B8 has received a commitment for "priority review" from the FDA.
BENNETT
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News